Bumper Offer - Urjas oil Just @ Rs. 1
Clopitab CV 20 Capsule (15) is a prescription drug, available for use as Capsule. The alternative uses of Clopitab CV 20 Capsule (15) have also been explained below.
The optimal dosage of Clopitab CV 20 Capsule (15) is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Clopitab CV 20 Capsule (15) include Headache, Nasopharyngitis, Diarrhoea. Some other side effects of Clopitab CV 20 Capsule (15) have been listed ahead. Normally, these side effects of Clopitab CV 20 Capsule (15) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Clopitab CV 20 Capsule (15)'s effect during pregnancy is Moderate and Mild while nursing. In addition, Clopitab CV 20 Capsule (15)'s effects on the liver, heart and kidney are discussed below in the Clopitab CV 20 Capsule (15) related warnings section.
Clopitab CV 20 Capsule (15) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Alcoholism, Bleeding are examples of such conditions. Other contraindications of Clopitab CV 20 Capsule (15) have been discussed in the sections ahead.
Additionally, Clopitab CV 20 Capsule (15) may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Clopitab CV 20 Capsule (15) is safe while driving, and is is addictive in nature.
Clopitab CV 20 Capsule (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Clopitab CV 20 Capsule (15) safe for pregnant women?
Clopitab Cv can have harmful effects in pregnant women. If you experience any discomfort after using Clopitab Cv, then discontinue the use and take your doctor's advice.
Is the use of Clopitab CV 20 Capsule (15) safe during breastfeeding?
Clopitab Cv may have very limited harmful effects for breastfeeding women.
What is the effect of Clopitab CV 20 Capsule (15) on the Kidneys?
Clopitab Cv rarely harms the kidneys.
What is the effect of Clopitab CV 20 Capsule (15) on the Liver?
You may experience side effects on your liver after taking Clopitab Cv. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Clopitab CV 20 Capsule (15) on the Heart?
Clopitab Cv has very mild side effects on the heart.
Clopitab CV 20 Capsule (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Clopitab CV 20 Capsule (15) unless your doctor advises you to do so -
Is this Clopitab CV 20 Capsule (15) habit forming or addictive?
Clopitab CV 20 Capsule (15) is not addictive in nature.
Interaction between Food and Clopitab CV 20 Capsule (15)
Eating certain foods may increase the time it takes Clopitab CV 20 Capsule (15) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Clopitab CV 20 Capsule (15)
Information about the interaction of Clopitab CV 20 Capsule (15) and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
